CRIS Current Research Information System

CRISTIANO, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.733
NA - Nord America 1.142
EU - Europa 928
AF - Africa 126
SA - Sud America 102
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.105
CN - Cina 454
IT - Italia 449
SG - Singapore 443
VN - Vietnam 374
KR - Corea 114
HK - Hong Kong 112
NL - Olanda 81
DE - Germania 80
BR - Brasile 71
SE - Svezia 63
IN - India 57
FI - Finlandia 52
BD - Bangladesh 47
FR - Francia 42
CI - Costa d'Avorio 33
SC - Seychelles 32
GB - Regno Unito 29
JP - Giappone 28
IE - Irlanda 25
CA - Canada 20
AT - Austria 18
RU - Federazione Russa 18
TG - Togo 17
ZA - Sudafrica 16
ID - Indonesia 15
PH - Filippine 15
MX - Messico 13
TH - Thailandia 12
BG - Bulgaria 11
JO - Giordania 11
ES - Italia 10
PL - Polonia 10
TR - Turchia 10
EC - Ecuador 9
NG - Nigeria 9
AR - Argentina 8
CH - Svizzera 7
EG - Egitto 7
IQ - Iraq 7
LT - Lituania 7
PK - Pakistan 6
TW - Taiwan 6
PT - Portogallo 5
AU - Australia 4
BE - Belgio 4
IR - Iran 4
SA - Arabia Saudita 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
MA - Marocco 3
MK - Macedonia 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
RS - Serbia 2
SI - Slovenia 2
AL - Albania 1
BO - Bolivia 1
ET - Etiopia 1
GD - Grenada 1
GH - Ghana 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LI - Liechtenstein 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
UA - Ucraina 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.037
Salva come PNG Salva come JPEG
Città #
Singapore 324
Hefei 181
Ashburn 170
Ho Chi Minh City 111
San Jose 109
Bologna 108
Seoul 104
Hong Kong 101
Hanoi 94
Chandler 66
Dallas 56
New York 56
Milan 54
Helsinki 39
Boardman 36
Ann Arbor 35
Abidjan 33
Beijing 31
Council Bluffs 31
Santa Clara 31
Dublin 25
Los Angeles 23
Tokyo 22
Rome 21
Lauterbourg 19
Fairfield 17
Frankfurt am Main 17
Lomé 17
Bengaluru 16
Haiphong 16
Johannesburg 16
Amsterdam 15
Da Nang 14
Munich 14
Princeton 14
São Paulo 14
Buffalo 13
Florence 13
Amman 11
Redmond 11
Sofia 11
Turin 11
Vienna 11
Southend 10
Abeokuta 9
Atlanta 9
Guangzhou 9
Jakarta 9
Stockholm 9
Falkenstein 8
Nuremberg 8
Orem 8
Redondo Beach 8
Tianjin 8
Bangkok 7
Bremen 7
Lappeenranta 7
London 7
Shanghai 7
Chicago 6
Parma 6
Ravenna 6
Reggio Emilia 6
Tongling 6
Toronto 6
Warsaw 6
Wilmington 6
Wuhan 6
Biên Hòa 5
Castel Maggiore 5
Cesena 5
Cosenza 5
Irvine 5
Mexico City 5
Modena 5
Montreal 5
Nanjing 5
Naples 5
Paris 5
Phoenix 5
San Francisco 5
Seattle 5
Treviglio 5
Turku 5
York 5
Ankara 4
Berlin 4
Boston 4
Brussels 4
Chengdu 4
Des Moines 4
Fortaleza 4
Hyderabad 4
Hải Dương 4
New Delhi 4
Osimo 4
Piscataway 4
Quito 4
Riyadh 4
Shijiazhuang 4
Totale 2.460
Salva come PNG Salva come JPEG
Nome #
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 283
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 232
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 230
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients 229
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 224
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 208
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents 203
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 193
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia 189
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia 185
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 182
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study 173
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells 165
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 163
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 156
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 152
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 127
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment 126
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells 123
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 114
COMPARISON BETWEEN NGS IGH/TCR AND RT-PCR BCR::ABL1 MINIMAL RESIDUAL DISEASE IN PH+ ACUTE LYMPHOBLASTIC LEUKEMIA: A PRELIMINARY ANALYSIS 111
Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia 101
Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia 86
Extracellular Vesicle-Based Liquid Biopsy Shows Clinical Relevance and Reveals Links with Single-Cell Metabolic Signature in Acute Myeloid Leukemia 67
Acute myeloid leukemia mutations: Therapeutic implications 54
IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual Disease 40
Totale 4.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.833
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022213 1 0 6 10 15 8 9 32 16 30 57 29
2022/2023386 37 43 10 35 54 31 10 38 68 8 32 20
2023/2024208 16 19 9 28 15 34 7 18 11 16 29 6
2024/2025863 26 102 46 48 41 38 83 56 56 81 103 183
2025/20262.435 215 335 199 220 155 109 206 87 481 169 150 109
Totale 4.116